Поставщик медицинского оборудования Medline планирует крупнейшее IPO

Stock Market News

16 December 2025, 19:05

Американская компания Medline Inc., производитель и поставщик медицинских и хирургических изделий, планирует разместить свои акции на Nasdaq под тикером MDLN, сообщает Bloomberg.

Компания рассчитывает установить цену размещения в верхней половине диапазона $26–$30 за акцию. Общее количество предлагаемых бумаг составит 179 млн акций.

При продаже по максимальной цене Medline привлечет $5,37 млрд, что может сделать размещение крупнейшим в 2025 году, превысив показатель китайской CATL ($5,26 млрд). Среди инвесторов компании значатся Blackstone Inc. (BX), Carlyle Group Inc. (CG) и Hellman & Friedman.

За девять месяцев 2025 года выручка Medline выросла до $20,6 млрд, скорректированная EBITDA достигла $2,66 млрд, а чистая прибыль составила $977 млн. Организаторами размещения выступают Goldman Sachs (GS), Morgan Stanley (MS), Bank of America (BAC) и JPMorgan Chase (JPM).

16, Dostyk street, integral non-residential facility No.2, Yessil district Astana, Republic of Kazakhstan (Talan Towers Offices).

+7 7172 67 77 55 - Free from landline numbers in Kazakhstan; calls from international and mobile numbers are chargeable.

7555 - free from mobile operators in Kazakhstan [email protected], [email protected]

Notify about fraudulent activities or security issues regarding this resource: fbroker.kz/trustcenter

Owning securities and other financial instruments is always associated with risks: the value of securities and other financial instruments can both rise and fall. Past investment results do not guarantee future income. In accordance with the law, the company does not guarantee or promise future returns on investments, nor does it provide guarantees regarding the reliability of potential investments or the stability of potential income.

Freedom Finance Global PLC provides brokerage (agency) services in the securities market on the territory of the Astana International Financial Center (hereinafter referred to as AFSA) in the Republic of Kazakhstan. Subject to compliance with requirements, conditions, restrictions and/or directions of the Acting Law of the AFSA, the Company is authorized to conduct the following Regulated Activities under License No. AFSA-A-LA-2020-0019: Dealing in Investments as Principal, Dealing in Investments as Agent, Managing Investments, Advising on Investments, Arranging Deals in Investments.

S&P Global ratings – “B+/B”, outlook “Positive”.

Ownership of securities and other financial instruments always involves risks: the cost of securities and other financial instruments may rise or fall. Past investment results do not guarantee future returns. In accordance with the legislation, the company does not guarantee or promise the profitability of investments in the future, does not guarantee the reliability of possible investments and the stability of the amount of possible income.

The information on the website is updated as part of keeping the data up-to-date and meeting regulatory disclosure requirements. Please note that these updates are for informational purposes only and are not marketing materials!